4.8 Article

HSV-1 and Zika Virus but Not SARS-CoV-2 Replicate in the Human Cornea and Are Restricted by Corneal Type III Interferon

Journal

CELL REPORTS
Volume 33, Issue 5, Pages -

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2020.108339

Keywords

-

Categories

Funding

  1. Washington University Chancellors Graduate Fellowship Program
  2. Initiative to Maximize Student Development
  3. NIH [R01 AI087682, R01 AI130454, R21 AI155380, K08 AR070918, R21 EY027870, R01 AI143982, R01 EY027870, 5P30 002687]
  4. Department of Defense [W81XWH-17-1-0111]
  5. Starr Foundation
  6. NIH/National Center for Advancing Translational Sciences (NCATS) [UL1 TR002345]
  7. Research to Prevent Blindness
  8. Jeffery Fort Innovation Fund
  9. MidAmerica Transplant
  10. NATIONAL EYE INSTITUTE [P30EY002687] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Here, we report our studies of immune-mediated regulation of Zika virus (ZIKV), herpes simplex virus 1 (HSV-1), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the human cornea. We find that ZIKV can be transmitted via corneal transplantation in mice. However, in human corneal explants, we report that ZIKV does not replicate efficiently and that SARS-CoV-2 does not replicate at all. Additionally, we demonstrate that type III interferon (IFN-lambda) and its receptor (IFN lambda R1) are expressed in the corneal epithelium. Treatment of human corneal explants with IFN-lambda, and treatment of mice with IFN-lambda eye drops, upregulates antiviral interferon-stimulated genes. In human corneal explants, blockade of IFN lambda R1 enhances replication of ZIKV and HSV-1 but not SARS-CoV-2. In addition to an antiviral role for IFN lambda R1 in the cornea, our results suggest that the human cornea does not support SARS-CoV-2 infection despite expression of ACE2, a SARS-CoV-2 receptor, in the human corneal epithelium.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available